Cite

HARVARD Citation

    Escribano-Subias, P. et al. (2019). Ambrisentan for treatment of inoperable chronic thromboembolic pulmonary hypertension (CTEPH). Pulmonary circulation. p. . [Online]. 
  
Back to record